Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Radiotherapy × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 12 Prostatic Neoplasms 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 7 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Radiation Injuries 3 Esophageal Neoplasms 3 Carcinoma 3 Vaginal Neoplasms 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Follicular 2 Liposarcoma 2

Interventions

Cyclophosphamide 7 fludarabine 6 fludarabine phosphate 3 Specimen Handling 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 zanubrutinib 2 polatuzumab vedotin 2 pirtobrutinib 2 obinutuzumab 2 glofitamab 2 Leukapheresis 2 Biopsy 2 tazemetostat 1 tafasitamab 1 pomalidomide 1 loncastuximab tesirine 1 ibrutinib 1 decitabine and cedazuridine drug combination 1 belinostat 1 axicabtagene ciloleucel 1 X-Rays 1 Vincristine 1 Prednisone 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Phantoms, Imaging 1 Nivolumab 1 MLN 8237 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡